BMT/SCT
Showing 1 - 25 of 659
Acute Myeloid Leukemia (AML) Trial in Charlotte (Allogeneic HCT, Consolidation chemo)
Terminated
- Acute Myeloid Leukemia (AML)
- Allogeneic HCT
- Consolidation chemotherapy
-
Charlotte, North CarolinaLevine Cancer Institute
Apr 19, 2022
Acute Biphenotypic Leukemia, Acute Leukemia, Acute Leukemia of Ambiguous Lineage Trial in United States (radiation, drug,
Recruiting
- Acute Biphenotypic Leukemia
- +11 more
- Total-Body Irradiation
- +8 more
-
Los Angeles, California
- +9 more
Aug 19, 2022
Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Acute Myeloid
Recruiting
- Acute Lymphoblastic Leukemia in Remission
- +11 more
- Astatine At 211 Anti-CD45 Monoclonal Antibody BC8-B10
- +8 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Oct 24, 2022
Intestinal Microbiota in Stem Cell Transplant Transplant
Recruiting
- Stem Cell Transplant Complications
- intestinal microbiota
-
Detroit, MichiganHenry Ford Health System
Dec 27, 2022
Bone Marrow Transplant, Stem Cell Transplant Trial in Aurora (Zoster Vaccine Recombinant)
Not yet recruiting
- Bone Marrow Transplant
- Stem Cell Transplant
- Zoster Vaccine Recombinant
-
Aurora, ColoradoUniversity of Colorado Hospital
Mar 17, 2023
Acute Myeloid Leukemia in Remission Trial in France (Fludarabine, Busulfan, ATG)
Not yet recruiting
- Acute Myeloid Leukemia in Remission
- Fludarabine
- +3 more
-
Nantes, Loire Atlantique, France
- +22 more
Jun 15, 2023
Acute Leukemia Trial (Rifaximin with allogeneic stem cell transplant, Allogeneic stem cell transplant)
Not yet recruiting
- Acute Leukemia
- Rifaximin with allogeneic stem cell transplant
- Allogeneic stem cell transplant
- (no location specified)
Sep 21, 2023
Hematological Disease, Immune Deficiencies, Solid Tumors Trial in Rochester (radiation, drug, procedure)
Completed
- Hematological Disease
- +5 more
- Total Body Irradiation 1200 cGy
- +9 more
-
Rochester, New YorkWilmot Cancer Institute
Nov 1, 2021
Sickle Cell Disease, Sickle Cell Anemia Trial run by the NHLBI (Biotin label)
Recruiting
- Sickle Cell Disease
- Sickle Cell Anemia
- Biotin label
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 11, 2022
Bone Marrow Fibrosis Trial in Germany (Allogeneic stem cell transplantation, Ruxolitinib continuous therapy)
Active, not recruiting
- Bone Marrow Fibrosis
- Allogeneic stem cell transplantation
- Ruxolitinib continuous therapy
-
Aachen, Germany
- +13 more
Aug 20, 2021
Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Baltimore (Azacitidine, Sargramostim)
Completed
- Acute Myeloid Leukemia
- Myelodysplastic Syndrome
- Azacitidine
- Sargramostim
-
Baltimore, MarylandThe Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sep 23, 2022
Allogeneic Hematopoietic Stem Cell Transplantation in Reunion
Not yet recruiting
- Allogeneic Hematopoietic Stem Cell Transplantation
- questionnaire
-
Saint-Pierre, FranceCHU de la Réunion
Apr 14, 2022
Bone Marrow Transplant Complications, Sinusoidal Obstruction Syndrome, Veno-occlusive Disease Trial in Kansas City (Ultrasound
Active, not recruiting
- Bone Marrow Transplant Complications
- +3 more
- Ultrasound Examination
-
Kansas City, MissouriChildren's Mercy Hospital
Jun 3, 2022
Leukemia, Myeloid, Acute, MDS, Myelodysplastic Syndrome Acute Myeloid Leukemia Trial in Denver (Nivolumab)
Withdrawn
- Leukemia, Myeloid, Acute
- +2 more
-
Denver, ColoradoColorado Blood Cancer Institute
Apr 20, 2021
Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, Allogeneic Hematopoietic Stem Cell
Completed
- Acute Lymphoblastic Leukemia in Remission
- +6 more
- Allogeneic Bone Marrow Transplantation
- +8 more
-
Houston, TexasM D Anderson Cancer Center
Dec 15, 2021
Chronic GVHD, Chronic Graft-Versus-Host-Disease, Bronchiolitis Obliterans Syndrome Trial run by the National Cancer Institute
Recruiting
- Chronic Graft vs Host Disease
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 18, 2022
Previously Treated Myelodysplastic Syndrome, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid
Recruiting
- Previously Treated Myelodysplastic Syndrome
- +3 more
- Fludarabine Phosphate
- +9 more
-
Chicago, IllinoisUniversity of Chicago Comprehensive Cancer Center
Jan 7, 2022
GVHD Trial in Ramat Gan (Cyclophosphamide, anti-human T-lymphocyte immunoglobulin (ATLG))
Recruiting
- Graft Versus Host Disease
- Cyclophosphamide
- anti-human T-lymphocyte immunoglobulin (ATLG)
-
Ramat Gan, IsraelChaim Sheba Medical Center
May 4, 2022
Tube Feeding in Children Having a Bone Marrow Transplant
Active, not recruiting
- Bone Marrow Disease
- +5 more
- Enteral feeding tubes
-
London, United KingdomGreat Ormond Street Hospital
Aug 2, 2022
Psychopathology Trial (Self-Compassionate Touch Intervention, Habit Formation Tools)
Not yet recruiting
- Psychopathology
- Self-Compassionate Touch Intervention
- Habit Formation Tools
- (no location specified)
May 18, 2023
Sickle Cell Trait (AUNT)
Recruiting
- Sickle Cell Trait
- Biologic Specimen Collection
-
Birmingham, Alabama
- +5 more
Oct 4, 2023
Chronic GVHD Trial in Atlanta (Belumosudil, Rituximab)
Not yet recruiting
- Chronic Graft Versus Host Disease
-
Atlanta, GeorgiaNorthside Hospital
Sep 21, 2023